Connect with:
Friday / December 20. 2024

logo
mobile-logo
HomePosts Tagged "Founder and CEO of Bionema Group"
Agbiologicals, Agribusiness, Biofertilizers, Company News, Europe, Fungicides, Herbicides

Company’s goal is to lead the way in biological agriculture technology, reducing reliance on synthetic pesticides and fertilisers.

Bionema Group, a UK-based R&D company and winner of the King’s Award for Innovation announced a tender for marketing its groundbreaking range of environmentally friendly plant health management products for agriculture, horticulture, sports turf, and forestry. These innovative solutions are designed to enhance plant health, reduce the use of synthetic fertilisers, increase crop performance and yields, and improve soil health.

In response to growing public concern over the impact of synthetic fertilisers on soil health and the environment, Bionema is committed to providing comprehensive, eco-friendly alternatives.  Bionema’s extensive collection of researched biostimulants and biofertilisers offers practical solutions tailored for greenkeepers, racecourse managers, groundsmen, farmers, and foresters.  This initiative builds on Bionema’s product and technology acquisition by Syngenta in 2021, reinforcing our position as a global leader in plant health management, and introduces products based on advanced Biofilm technology.

Bionema has been at the forefront of developing sustainable agricultural products at Swansea University, Wales, headquarters for decades. Our growth aligns with evolving market demands, particularly in light of the EU’s commitment to reducing synthetic fertiliser use by 20 per cent by 2030. 

Our diverse range of products includes biostimulants such as PGPR, nutrients, prebiotics & vitamins, triacontanol, acetyl thiazolidine carboxylic acid, and calcium peroxide. 

Our biofertilisers feature nitrogen-fixing bacteria, phosphorus-solubilizing bacteria, silica solubilizing bacteria, potash-mobilizing bacteria, sulphur-mobilizing bacteria, iron-mobilising bacteria, zinc-mobilizing bacteria, and manganese-mobilizing bacteria, all meticulously formulated to meet the needs of our customers.

Dr Minshad Ansari, Founder and CEO of Bionema Group, shared the company’s visionary outlook, “Our goal is to lead the way in Biological Agriculture technology, reducing reliance on synthetic pesticides and fertilisers. Sustainable alternatives are essential with global trends shifting and increasing demands from consumers, society, and regulators. The EU’s ambitious plan to ban 50 per cent of pesticides by 2030 and significantly expand organic farming necessitates innovative solutions like ours. The EU aims to reduce fertiliser use by at least 20% by 2030 as part of its Farm to Fork Strategy, focusing on decreasing nutrient losses by 50% without compromising soil fertility and increasing organic farming land by up to 25%.”

Dr Ansari emphasised, “While we are excited to introduce our new products, our unwavering commitment to innovation and collaboration continues. We have achieved significant milestones, but our journey of progress is far from over. We are confident that the best is yet to come.”

Company’s goal is to lead the way

Agbiologicals, Agribusiness, Biofertilizers, Fungicides

This strategic initiative solidifies Bionema’s position as a global leader in crop protection and plant health management.

 Bionema Group, a renowned developer of sustainable agricultural biological solutions, announced a tender for marketing its pioneering range of environmentally friendly plant health management products for agriculture, horticulture, sports turf and forestry. These novel solutions promote plant health, reduce synthetic fertilisers, boost crop performance and yields, and improve soil health.

As public awareness and concerns regarding the impact of synthetic fertile on soil health and the environment continue to escalate, Bionema endeavours to offer a comprehensive collection of over 40 biostimulants, biofertilisers and biosurfactants products and technologies, providing practical, eco-friendly alternatives. This strategic initiative follows Bionema’s product technology acquired by Syngenta in 2021, solidifying its position as a global leader in crop protection and plant health management.

Over the past decades, Bionema has experienced significant growth to meet the evolving demands of the market. Its diverse product range now encompasses Biocontrol, Biostimulants, Biofertilisers, and Efficacy Boosters tailored to agriculture, horticulture, sports turf and forestry.

Dr Minshad Ansari, Founder and CEO of Bionema Group, articulated the company’s vision: “Our objective is to lead as innovators in Biological Agriculture technology, reducing dependency on synthetic pesticides and fertilisers. With shifting global trends and heightened demands from consumers, society, and regulators, sustainable alternatives are imperative. For instance, consider the EU’s ambitious plan to ban 50 per cent of pesticides by 2030 and significantly ramp up organic farming. Achieving such targets necessitates innovative solutions like the ones we are introducing. The EU aims to reduce fertiliser use by at least 20 per cent by 2030 as part of its Farm to Fork Strategy. These regulations focus on decreasing nutrient losses by 50 per cent without harming soil fertility and increasing organic farming land by up to 25 per cent”.

Bionema’s expanded portfolio significantly bolsters its presence in the Biological Agriculture sector, complementing its ongoing research and development, farmer training, and additional services to advance biological solutions in various cropping systems.

The company’s innovative formulation and delivery platform technology facilitates the development of products boasting 20-30 per cent higher efficacy and productivity compared to existing alternatives.

Dr Ansari emphasised, “While we are delighted to unveil our new products, our commitment to innovation and collaboration remains steadfast. We have achieved noteworthy milestones, yet our dedication to progress persists, and we firmly believe that the best is yet to come.”

This strategic initiative solidifies Bionema’s position as

Agbiologicals, Agribusiness, Biofertilizers, Company News, Europe

The company’s innovative formulation and delivery platform technology enable the development of products with 20-30 per cent higher efficacy and productivity compared to existing products.

Bionema Group, a leading developer of sustainable biocontrol solutions, announced a tender for the marketing of their innovative range of environmentally friendly biological products. These groundbreaking solutions are designed to address crop protection and plant health management in the Agriculture, Sport Turf Amenity, Horticulture, Agriculture, and Forestry sectors.

As public awareness and concerns regarding the impact of agrochemicals (pesticides and fertilisers) on human health, biodiversity, soil health and the environment continue to rise, Bionema aims to provide a complete collection of more than 60 biological products and technology that offer effective, eco-friendly alternatives. This strategic move follows Bionema’s transformative deal with Syngenta in 2021, congealing their position as a world-leading biocontrol technology company.

Over the past 15 months, Bionema has undergone significant growth to meet the progressing needs of the market. Their different product range now includes Biocontrol, Biostimulants, Biofertiliser and Efficacy Booster customised to agriculture, horticulture, forestry, turf & amenities, and public health.

Dr Minshad Ansari, Founder and CEO of Bionema Group, expressed the company’s vision, said, “Our goal is to be at the forefront of Biological Agriculture technology innovator, reducing reliance on chemical pesticides. With changing global trends and increasing demands from consumers, society, and regulators, sustainable alternatives are urgently needed. For instance, consider the EU’s aspiring plan to ban 50 per cent pesticides by 2030 and significantly increase organic farming. Achieving such targets requires innovative solutions like the ones we are introducing”.

Bionema’s expanded portfolio significantly enhances their presence in the Biological Agriculture sector, complementing their ongoing R&D, farmer’s training, and additional services focused on advancing biological solutions in different cropping systems.

The company’s innovative formulation and delivery platform technology enable the development of products with 20-30 per cent higher efficacy and productivity compared to existing products.

Dr Ansari stressed, “While we are pleased to introduce our new products, our commitment to innovation and collaboration remains unwavering. We have achieved significant milestones, but our dedication to progress continues, and we firmly believe that the best is yet to come”.

The company's innovative formulation and delivery platform

Biostimulants, Company News, Europe, Horticulture

The Bionema team conducted a series of glasshouse and field trials across various locations including the UK, EU, India, Canada and Mexico.

Bionema Group, a prominent biocontrol technology developer and manufacturer specialising in crop protection and plant health management, has unveiled a new biostimulant product in the UK developed for application in agriculture, horticulture, forestry, turf, and amenities.

After a decade of dedicated Research and Development, Bionema Group is proud to introduce RootVita®, a groundbreaking product that harnesses the power of nature to revolutionise plant growth and soil health. RootVita® is a potent blend of biofertilisers, PGPR (Plant Growth Promoting Rhizobacteria), essential nutrients, prebiotics, and vitamins.

Plants treated with RootVita® exhibit improved resistance to abiotic stress factors such as heat, drought and salt. Additionally, their roots tend to access more nutrients and absorb water more effectively.

The Bionema team conducted a series of glasshouse and field trials across various locations including the UK, EU, India, Canada and Mexico. The results of these trials suggest that RootVita® has the potential to enable farmers to reduce their fertiliser usage by up to 30 per cent, all while maintaining approximately 93 per cent of their crop yields. Specifically, in Bionema’s glasshouse trials, root growth was observed to be 35 per cent more robust when using a recommended mixture of 50 per cent fertiliser in combination with Bionema’s RootVita® product.

According to Dr Minshad Ansari, Founder and CEO of Bionema Group, “There has been a notable surge in interest surrounding biostimulants in recent years, driven by the increasing recognition of their benefits. Looking ahead, with the overall Biocontrol market anticipated to experience a compound annual growth rate (CAGR) of 13.7 per cent over the next five years, the biostimulant segment within this market is expected to grow at a rate of 11.8 per cent, reaching a value of $6.2 billion by the year 2027 (source: Markets and Markets, 2022). This rapid market expansion mirrors public concerns regarding the impacts of agrichemicals on human health, biodiversity, and the environment. Consequently, there is a growing demand for natural solutions to enhance crop yields and promote plant health”.

Bionema’s expanded portfolio enhances the company’s offering to the Biological Agriculture sector, and complements its ongoing research, training and other services in the continuing development of novel biological solutions. It reflects Bionema’s evolution in focus and strategy, announced in 2022 following the company’s deal with Syngenta that secured Bionema’s position as a top 20 world-leading biocontrol company.

Dr Ansari further emphasised Bionema’s aspiration to become a prominent developer of biocontrol technology, with the aim of diminishing reliance on chemical pesticides. He pointed out that the world is undergoing a transformation, marked by increasing calls for reduced chemical usage in agriculture. In order to sustain high crop yields and provide for a growing global population, it is imperative that we explore alternative, more sustainable approaches. Biostimulants emerge as a promising option to meet these demands.

The Bionema team conducted a series of